KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, www.pvct.com), a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus”), today announced that it will host its fourth quarter and year-end 2015 conference call on Thursday, March 10, 2016, at 4:00 p.m. Eastern Standard Time.
